Last reviewed · How we verify
Ketorolac Injection 60 mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Ketorolac Injection 60 mg (Ketorolac Injection 60 mg) — William Beaumont Army Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ketorolac Injection 60 mg TARGET | Ketorolac Injection 60 mg | William Beaumont Army Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ketorolac Injection 60 mg CI watch — RSS
- Ketorolac Injection 60 mg CI watch — Atom
- Ketorolac Injection 60 mg CI watch — JSON
- Ketorolac Injection 60 mg alone — RSS
Cite this brief
Drug Landscape (2026). Ketorolac Injection 60 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/ketorolac-injection-60-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab